European Medicines Verification Organisation Company Profile

07:39 EST 19th February 2019 | BioPortfolio

News Articles [2104 Associated News Articles listed on BioPortfolio]

Recipharm gains EU Hub's approval to submit serialisation data

Contract development and manufacturing organisation (CDMO) Recipharm has received approval by the European Medicines Verification Organisation (EMVO) to submit serialisation data to the European Hub.

Almost 1,500 pharma firms could miss FMD deadline, warns body in charge

Around 1,500 pharmaceutical companies are at risk of failure to comply with the Falsified Medicines Directive because they have yet to start working with the European Medicines Verification Organisat...

European Medicines Verification Organisation: Medicines Verification System Goes Live Across EU to Better Protect Patients from Falsified Medicines

As of 9 February 2019, the supply chain for dispensing medicines to patients in Europe will become even safer. Prescription medicines dispensed in Europe...

Plasticell receives EU funding as part of €3.7 million consortium

Plasticell Ltd, a developer of stem cell technologies and regenerative medicines, has announced that the Advanced Stem Cell Training Network (ASCTN), a European research consortium in which the compan...

Brexit proposals only promises 'possibility' of ties with EMA

The Brexit political agreement does not guarantee ties with the European Medicines Agency, despite government ministers emphasising the importance of the need for close relationships with the drugs sa...

EMA moves its headquarters from London

The European Medicines Agency (EMA) has begun its relocation from its headquarters in London to the organisation’s new location in...Read More... The post EMA moves its headquarters from London appe...

Migraine treatment Ajovy among CHMP’s six endorsed medicines 

Six medicines have taken a giant leap toward winning approval in Europe having won the backing of the European Medicines Agency’s (EMA) human medicines committee (CHMP).

Seven medicines leap closer to EU approval

The European Medicines Agency’s human medicines committee (CHMP) has put forward seven medicines for approval in the region.

Drugs and Medications [16 Associated Drugs and Medications listed on BioPortfolio]

Keytruda [merck sharp & dohme corp.]

These highlights do not include all the information needed to use KEYTRUDA safely and effectively. See full prescribing information for KEYTRUDA. KEYTRUDA(pembrolizumab) for injection, for intravenous...

Zydelig [gilead sciences, inc.]

These highlights do not include all the information needed to use ZYDELIG safely and effectively. See full prescribing information for ZYDELIG. ZYDELIG® (idelalisib) tablets, for oral useInitial U.S....

Radium ra 223 dichloride [cardinal health 414, llc]

Radium ra 223 dichloride injection

Greenglo [hub pharmaceuticals, inc.]

Green Glo (Lissamine Green)

Ibrance [u.s. pharmaceuticals]

These highlights do not include all the information needed to use IBRANCE safely and effectively. See full prescribing information for IBRANCE. IBRANCE (palbociclib) capsules, for oral useInitial U.S....

PubMed Articles [2026 Associated PubMed Articles listed on BioPortfolio]

Impact of Brexit on UK and EU Drug Regulation and Patient Access.

The chronology of U.K. leaving the European Union Is presented together with its implications for medicines regulation, including the move of the European Medicines Agency from London to Amsterdam, Th...

Evolution of Average European Medicine Prices: Implications for the Methodology of External Price Referencing.

There are indications of staggered market entry of medicines in the national markets, with medicines being marketed first in countries with high prices. This study aimed to analyse the availability an...

Improving the experience of death verification in the community.

Monitoring evidence on overall survival benefits of anticancer drugs approved by the European Medicines Agency between 2009 and 2015.

The introduction provisional approval strategies increases the approval of anticancer drugs with ambiguous benefit-risk profiles. Thus, in many instances, there is lacking evidence about overall survi...

International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV.

We validated the new European Organisation for Research and Treatment of Cancer Quality of Life Head and Neck Module (EORTC QLQ-HN43).

Clinical Trials [1319 Associated Clinical Trials listed on BioPortfolio]

Intravascular ECG During Insertion of Peripheral Inserted Central-venous Catheters: Replacement for Chest X-ray?

This study will provide further knowledge concerning the use of electrocardiography (ECG) signals for verification of peripherally inserted central catheter (PICC) tip placement. Furthermo...

Polymedication-Check With Insight in Patients' Medication Organisation and Comprehension of Generics

Patients using multiple drugs including generics have found different solutions to manage their medication. During a Polymedication-Check (medication review type 2a service in community ph...

Evaluation of 3DCRT Versus IGRT and Analysis of Early Response in Head and Neck Cancer.

This study aims to study the impact image guided radiotherapy with Cone beam CT will have on the outcomes(toxicities and response) of head and neck cancer when compared to 3D conformal rad...

PENTA Fosamprenavir Study

Twice daily fosamprenavir, in combination with low dose ritonavir (FPV/RTV BID), is indicated for the treatment of HIV-infected adults, adolescents and children of 6 years of age and above...

European Compliance Study in Parkinson's Disease

In both symptomatic and asymptomatic disease, only about half of medicines are taken as prescribed1. Relatively little is known about how patients with Parkinson's disease take their medi...

Companies [1316 Associated Companies listed on BioPortfolio]

European Medicines Verification Organisation

European Plant Science Organisation

EPSO, the European Plant Science Organisation, is an independent body that represents more than 50 leading Research Institutions from 23 European countries. EPSO wants to improve impact and visibility...

European Medicines Agency

European Medicines Agency (EMEA) is a decentralised body of the European Union with headquarters in London.ts main responsibility is the protection and promotion of public and animal health, through t...

European Generic medicines Association

The EGA is the official representative body of the European generic pharmaceutical industry, which is at the forefront of providing high-quality affordable medicines to millions of Europeans and stimu...

European Directorate for the Quality of Medicines

The EDQM was created in 1996 and is a Directorate of the Council of Europe. Its premises have been especially designed for its various activities. Today the EDQM is organised into nine administrative...

More Information about "European Medicines Verification Organisation" on BioPortfolio

We have published hundreds of European Medicines Verification Organisation news stories on BioPortfolio along with dozens of European Medicines Verification Organisation Clinical Trials and PubMed Articles about European Medicines Verification Organisation for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of European Medicines Verification Organisation Companies in our database. You can also find out about relevant European Medicines Verification Organisation Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record